România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

teva pharmaceuticals s.r.l. - atomoxetinum - caps. - 10 mg - psihostimulante si nootrope simpatomimetice cu actiune centrala

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

teva pharmaceuticals s.r.l. - atomoxetinum - caps. - 18 mg - psihostimulante si nootrope simpatomimetice cu actiune centrala

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

teva pharmaceuticals s.r.l. - atomoxetinum - caps. - 25 mg - psihostimulante si nootrope simpatomimetice cu actiune centrala

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

teva pharmaceuticals s.r.l. - atomoxetinum - caps. - 40 mg - psihostimulante si nootrope simpatomimetice cu actiune centrala

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

teva pharmaceuticals s.r.l. - atomoxetinum - caps. - 60 mg - psihostimulante si nootrope simpatomimetice cu actiune centrala

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

teva pharmaceuticals s.r.l. - atomoxetinum - caps. - 80 mg - psihostimulante si nootrope simpatomimetice cu actiune centrala

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

teva pharmaceuticals s.r.l. - atomoxetinum - caps. - 100 mg - psihostimulante si nootrope simpatomimetice cu actiune centrala

Uniunea Europeană - română - EMA (European Medicines Agency)

santen oy - latanoprost, netarsudil mesilate - glaucoma, open-angle; ocular hypertension - oftalmologice - roclanda is indicated for the reduction of elevated intraocular pressure (iop) in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient iop reduction.

Uniunea Europeană - română - EMA (European Medicines Agency)

ceva santé animale - benazepril hydrochloride, spironolactone - sistemul cardiovascular - câini - pentru tratamentul insuficienței cardiace congestive cauzate de boala cronică degenerativă cronică la câini (cu suport diuretic, după caz).

Uniunea Europeană - română - EMA (European Medicines Agency)

ceva santé animale - inactivat de vaccin coxiella burnetii, tulpina nine mile - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus. , onset of immunity: not established. , duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta. , onset of immunity: not established. , duration of immunity: one year after completion of the primary vaccination course.